£10.4M
The digital healthcare consent platform has secured backing from Maven and Catapult to fund product development and international growth.
"We are really pleased to welcome Maven and the angel investors alongside our existing shareholders."
C
Catapult
Venture CapitalPortfolio
1
companies
Portfolio companies
Team
CS
Chris Spencer
Venture Partner
Chris brings health tech and venture experience from roles including health tech CEO, non-executive chair, and venture partner at Catapult. He also maintains involvement in the arts as a chorus bass with the Royal Scottish National Orchestra.
